Vyzkoušet demo Otevřít účet
Obchodování
CFD
Binární opce
Krypto
Bankovnictví
B2B
Zprávy z trhu
O nás
Vyzkoušet demo Otevřít účet

Bayer Leads the DAX

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Bayer shares rose significantly (reaching EUR 45.01, up 2.34%) following the approval of its stroke prevention drug Asundexian in China. It is the world's first FXIa inhibitor on the market, offering a lower bleeding risk than traditional blood thinners. Positive Phase-3 study results for its prostate cancer drug Nubeqa also boosted the stock.
Back to articles

Actual Topics

26 Oct 2026

Novartis Q3 Preview: YTD Outperformance Meets Rising Defensive Demand

Novartis will announce its Q3 earnings before the market opens on October 27, followed by a conference call at 8:00 AM ET (1:00 PM CET). Analysts expect the company to report a 4.6% year-over-year revenue increase, reaching between $14.53 billion and $14.56 billion, along with a consensus EPS of $2.25.Novartis AG Weekly Chart Year-to-date in 2026, Novartis AG has delivered more

26 Oct 2026

Halifax and Lloyds Bank November Branch Closures

Lloyds Banking Group is closing 17 Halifax and Lloyds bank branches across the UK in November due to a shift toward online banking. Customers can still access basic services at Post Offices or utilize mobile banking and banking hubs.

26 Oct 2026

Volvo Shares Plunge Amid China Sales Slump

Volvo Cars shares plunged on Friday, wiping out over a quarter of the Swedish automaker's market value following a rapid deterioration of sales in China. In response to intensifying competition and a nearly 50% drop in Chinese quarterly sales, the company announced plans to cut 2,500 jobs and reduce research and development spending. Despite the turbulence in the Asian and